Warren Buffett reportedly loses a big takeover battle

Warren Buffett didn't become the world's fourth-wealthiest person by getting outbid on deals.

News: What you need to know about the markets     Warren Buffett reportedly loses a big takeover battle Warren Buffett didn't become the world's fourth-wealthiest person by getting outbid on deals. Read more »   America's stock market is shrinking. NYSE has a plan for that America's stock market is shrinking. The number of public companies has been cut roughly in half over the past two decades, mostly by choice. Read more »   For the next 26 days, retailers will be after your wallet Happy Friday. A version of this story first appeared in CNN Business' Before the Bell newsletter. Not a subscriber? You can sign up right here. Read more »   India's economic growth rate has halved in just three years Three years ago, India was enjoying economic growth of about 9%. Now the rate of expansion has slumped to just half that. Read more »   South Korea didn't buy any beer from Japan last month Beer guzzlers are feeling the impact of the South Korea-Japan trade war. Read more »   Gold cards for everyone. How a bank for the forgotten made its investors very rich How do you get a stock to increase 144,000% in less than two decades? For one South African bank, the answer is a relentless focus on customers others forgot. Read more »

Dow Nasdaq S&P -112.59   -39.70   -12.65 28,051.41   8,665.47   3,140.98 -0.40%   -0.46%   -0.40% YTD +20.25%   YTD +30.60%   YTD +25.30%

Biggest Winners NRG Energy Inc +1.69%   HP Inc +1.47%   CF Industries Holdings Inc +1.23%   DXC Technology Co +1.06% Biggest Losers Apache Corp -4.05%   TechnipFMC PLC -3.38%   Devon Energy Corp -2.75%   Kohls Corp -2.71%

Hottest ETF NYSE Market Volume

Key Market Stats Latest Today's Change Oil $58.14 -0.18 / -0.31% Gold $1,470.40 -2.30 / -0.16% 10-yr 1.78% +0.04 Euro $1.10 +0.00 / +0.07%

Hi, let us know what you think of this newsletter!   Tell us what you want to read more of... and less of. Email your tips and feedback to MarketsNowFeedback@turner.com

Sign up for Reliable Sources newsletter   Sign up for Before the Bell newsletter

Tips, thoughts or questions are always welcome at MarketsNowFeedback@turner.com   ® © 2016 Cable News Network Inc. A WarnerMedia Company. All Rights Reserved. You are receiving this message because you subscribed to CNN Business's "Markets Now" newsletter. Our Mailing address is: Cable News Network, Inc. Attention: Privacy Policy Coordinator One CNN Center, 13 North Atlanta, GA 30303

                                                 

This email was sent to adsbimasakti.bhinnekanews@blogger.com why did I get this?    unsubscribe from this list    update subscription preferences Cable News Network, Inc. · Attention: Privacy Policy Coordinator · One CNN Center, 13 North · Atlanta, GA 30303 · USA

Reuters Health Report: Fired Zimbabwe state doctors reject offer to return to work

Visit Reuters.com for the latest news

Reuters Health Report Your Daily Briefing       Tweet       Share Fired Zimbabwe state doctors reject offer to return to work Zimbabwe state doctors who were fired for going on strike have rejected a government offer to return to work, their union said on Friday. AstraZeneca's Imfinzi gets speedy FDA review for small cell lung cancer British drugmaker AstraZeneca Plc said on Friday its immunotherapy cancer treatment Imfinzi has been granted a speedy review by the U.S. medicines watchdog for the treatment of a particularly aggressive type of lung cancer. Samoa measles toll hits 42 as nations dispatch medical teams, supplies More nations were flying medical staff and supplies to Samoa on Friday to battle a measles outbreak that prompted the Pacific island nation to declare a state of emergency this month, as the death toll rose to 42, most of them children younger than four. Four killed in attacks against Ebola response centers in Congo Militia fighters in eastern Congo killed four people and injured several others in attacks on two Ebola response centers on Thursday, in what responders described as a serious setback to efforts to contain the epidemic. Novartis's $90 million Swiss factory to help solve cell therapy bottleneck Swiss drugmaker Novartis's new $90 million cell and gene therapy factory in northern Switzerland is on track to begin commercial production of its cell therapy Kymriah for cancer in 2020. Inducing labor at 41 weeks safer than 'wait and see' approach (Reuters Health) - For late-term pregnancies, inducing labor at 41 weeks may be safer than waiting until week 42, a large Swedish study suggests. No evidence stretching prevents running injuries (Reuters Health) - It's a common and persistent myth that static stretching improves running performance and decreases the risk of injuries, researchers say. Large waist in normal-weight elderly tied to higher dementia risk (Reuters Health) - Older adults with normal weight but a wider waist may be at a higher risk of developing dementia, a Korean study suggests. ImmuPharma licenses lupus drug Lupuzor to Avion in the United States British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals. China reports fourth case of plague this month Chinese health authorities on Thursday reported a fresh case of bubonic plague in the country's northern Inner Mongolia region, bringing the total number of plague cases to four since the beginning of the month. Massachusetts adopts tough ban on flavored vaping, tobacco products Massachusetts on Wednesday adopted the country's toughest ban on the sale of flavored tobacco and vaping products, including menthol cigarettes, in response to a rise in youth vaping and an outbreak of vaping-related serious lung injuries. Related Videos Swift takes high road, makes history, at AMAs Entertainment Thieves grab jewels, treasures worth 'up to a billion euros' in Dresden Arts Introducing the all-new Reuters News app The new Reuters News app is here, redesigned from the ground up to fit your busy life. Get it now on iOS Your world. Your news. More Newsletters Get Reuters News App Get Reuters TV App               © 2019 Thomson Reuters. All rights reserved. 3 Times Square, New York, NY 10036 Email Preferences    |   Privacy Policy    |   Terms and Conditions